This paper examines the uses and limits oi empirical data in evaluating mea
surement and modeling approaches to human lead exposure. Empirical data fro
m experiment or observation or both have been used in studies of lead expos
ure. For example, experimental studies have elucidated and quantified physi
ologic or biokinetic parameters of lead exposure under controlled condition
s. Observation, i.e., epidemiology, has been widely applied to study popula
tion exposures to lead. There is growing interest in the use of lead exposu
re prediction models and their evaluation before use in risk assessment. Em
pirical studies of lead exposure must be fury understood, especially their
limits, before they are applied as "standards" or reference information for
evaluation of exposure models, especially the U.S. Environmental Protectio
n Agency's lead biokinetic model that is a focus oi this article. Empirical
and modeled datasets for lead exposure may not agree due to a) problems wi
th the observational data or bi problems with the model; caution should be
exercised before either a model or observational data are rejected. There a
re at least three sources of discordance in cases where there is lack of ag
reement: a) empirical data are accurate but the model is flawed, b) the mod
el is valid but reference empirical data are inaccurate; or c) neither empi
rical data nor model is accurate, and each is inaccurate in different ways.
This paper evaluates some of the critical empirical inputs to biokinetic m
odels, especially lead bioavailability.